- Kits & Reagents
- Instruments
Mycoplasma Testing Market size was valued at USD 734.9 Million in 2023 and is poised to grow at a significant CAGR of 13.8% over 2024-2030. Mycoplasma testing is a medical procedure done by medical professionals to help quickly detect or rule out mycoplasma contamination of cell cultures. This approach consists of tests that either assess antibodies in the blood generated in response to a mycoplasma infection or directly detect the organism by culture or detection of its genetic material (DNA) in a bodily sample.The kits & reagents segment is anticipated to grow at a significant CAGR over the forecast years owing to the increased usage of kit-based procedures for mycoplasma testing, as well as the frequent procurement of these consumables as opposed to equipment, which are major factors driving the expansion of this market sector. Moreover, the market players are focusing on launching new products, acquisitions, and collaboration. For Instance, In May 2022, Lonza, which is one of the leading organizations in the pharmaceuticals and biotech industry, announced the collaboration with Israel Biotech Fund to work in Biologics and Molecular development. Growing concerns over cell culture contamination, Increasing R&D efforts have anticipated in massive income for the market. Moreover, increasing use of breakthrough technology is projected to drive growth even further. Another aspect driving expansion is the rise in cell culture contamination.
Mycoplasma Testing Market Key Developments:
- In April 2022, Charles River Laboratories International announced the acquisition of Explora BioLabs, a vivarium research service provider. It will help the researchers and clients to boost the early-stage research comprehensively.
- In July 2020, Roche Diagnostics will introduce Cobas 6800, a fully automated system, in India.
Mycoplasma Testing Market Summary
Study Period
2024-30
Base Year
2023
CAGR
13.8%
Largest Market
North America
Fastest Growing Market
Asia Pacific
Mycoplasma Testing Market Dynamics
The growing need for mycoplasma testing, rising markets, and increased pharmaceutical outsourcing are the major drivers driving the growth of the mycoplasma testing market during the projected period. Furthermore, increased research and development in life science research and an increase in cell-line contamination contribute to the market's overall growth. Growing concerns about cell culture contamination are also likely to boost market expansion. However, new growing markets stymie market expansion. The market's progress is expected to be slowed down by downward pricing pressure due to its commodity character throughout the projected period.
North America Got Significant Share
Mycoplasma Testing Market Reginal Analysis
The Mycoplasma Testing market in North America is likely to hold the highest revenue share in 2021, and the same trend is expected over the forecast period due to growing healthcare spending and government funding to boost research-based activity in biopharmaceutical sectors, the manufacture of biopharmaceuticals in North America is also increasing, which necessitates the use of highly pure cultures in order to generate treatments. According to the National Science Foundation, the R&D industry in the United States grew significantly in 2019, which is predicted to favorable affect regional growth.
Latin America
Europe
Asia Pacific
Middle East
North America
Mycoplasma Testing Market Segmentation
By Product
By Technology
- PCR
- ELISA
- Direct Assay
- Indirect Assay
- Enzymatic Methods
- DNA Staining
- Others
By Application
- Cell Line Testing
- Virus Testing
- Others
By End User
- Academic Research Institutes
- Cell Banks
- Pharmaceutical & Biotechnology Companies
- Others
Frequently Asked Questions
The mycoplasma testing market is projected to expand at a CAGR of 13.8% during the forecast period
Thermo Fisher Scientific, Inc. (US), Charles River Laboratories International, Inc. (US), Lonza Group Ltd. (Switzerland), Merck KGaA (Germany), Roche Diagnostics (Switzerland), American Type Culture Collection (US), Bionique Testing Laboratories, Inc. (US), InvivoGen (US), PromoCell GmbH (Germany), Biological Industries Israel Beit Haemek Ltd. (Israel)
asia pacific is the fastest-growing region for mycoplasma testing market
Key Features of the Reports
- The mycoplasma testing market report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
- The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
- The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
- The report tracks recent innovations, key developments, and start-up details that are actively working in the market
- The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
| 1.Executive Summary |
| 2.Global Mycoplasma Testing Market Introduction |
| 2.1.Global Mycoplasma Testing Market - Taxonomy |
| 2.2.Global Mycoplasma Testing Market - Definitions |
| 2.2.1.Product |
| 2.2.2.Technology |
| 2.2.3.Application |
| 2.2.4. End User |
| 2.2.5.Region |
| 3.Global Mycoplasma Testing Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4.Global Mycoplasma Testing Market Analysis, 2019-2023 and Forecast 2024-2030 |
| 4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5.Global Mycoplasma Testing Market By Product, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
| 5.1. Kits & Reagents |
| 5.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Instruments |
| 5.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 6.Global Mycoplasma Testing Market By Technology, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
| 6.1. PCR |
| 6.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. ELISA |
| 6.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Direct Assay |
| 6.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 6.4. Indirect Assay |
| 6.4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.4.3. Market Opportunity Analysis |
| 6.5. Enzymatic Methods |
| 6.5.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.5.3. Market Opportunity Analysis |
| 6.6. DNA Staining |
| 6.6.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 6.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.6.3. Market Opportunity Analysis |
| 6.7. Others |
| 6.7.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 6.7.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.7.3. Market Opportunity Analysis |
| 7.Global Mycoplasma Testing Market By Application, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
| 7.1. Cell Line Testing |
| 7.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Virus Testing |
| 7.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Others |
| 7.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 8.Global Mycoplasma Testing Market By End User, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
| 8.1. Academic Research Institutes |
| 8.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Cell Banks |
| 8.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 8.3. Pharmaceutical & Biotechnology Companies |
| 8.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.3.3. Market Opportunity Analysis |
| 8.4. Others |
| 8.4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.4.3. Market Opportunity Analysis |
| 9.Global Mycoplasma Testing Market By Region, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
| 9.1. North America |
| 9.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 9.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.1.3. Market Opportunity Analysis |
| 9.2. Europe |
| 9.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 9.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.2.3. Market Opportunity Analysis |
| 9.3. Asia Pacific (APAC) |
| 9.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 9.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.3.3. Market Opportunity Analysis |
| 9.4. Middle East and Africa (MEA) |
| 9.4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 9.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.4.3. Market Opportunity Analysis |
| 9.5. Latin America |
| 9.5.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 9.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.5.3. Market Opportunity Analysis |
| 10.North America Mycoplasma Testing Market ,2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
| 10.1. Product Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.Kits & Reagents |
| 10.1.2.Instruments |
| 10.2. Technology Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.PCR |
| 10.2.2.ELISA |
| 10.2.3.Direct Assay |
| 10.2.4.Indirect Assay |
| 10.2.5.Enzymatic Methods |
| 10.2.6.DNA Staining |
| 10.2.7.Others |
| 10.3. Application Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.Cell Line Testing |
| 10.3.2.Virus Testing |
| 10.3.3.Others |
| 10.4. End User Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.4.1.Academic Research Institutes |
| 10.4.2.Cell Banks |
| 10.4.3.Pharmaceutical & Biotechnology Companies |
| 10.4.4.Others |
| 10.5. Country Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.5.1.United States of America (USA) |
| 10.5.2.Canada |
| 11.Europe Mycoplasma Testing Market ,2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
| 11.1. Product Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.Kits & Reagents |
| 11.1.2.Instruments |
| 11.2. Technology Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.PCR |
| 11.2.2.ELISA |
| 11.2.3.Direct Assay |
| 11.2.4.Indirect Assay |
| 11.2.5.Enzymatic Methods |
| 11.2.6.DNA Staining |
| 11.2.7.Others |
| 11.3. Application Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.Cell Line Testing |
| 11.3.2.Virus Testing |
| 11.3.3.Others |
| 11.4. End User Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.4.1.Academic Research Institutes |
| 11.4.2.Cell Banks |
| 11.4.3.Pharmaceutical & Biotechnology Companies |
| 11.4.4.Others |
| 11.5. Country Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.5.1.Germany |
| 11.5.2.France |
| 11.5.3.Italy |
| 11.5.4.United Kingdom (UK) |
| 11.5.5.Spain |
| 11.5.6.Rest of EU |
| 11.5.7. |
| 12.Asia Pacific (APAC) Mycoplasma Testing Market ,2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
| 12.1. Product Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.Kits & Reagents |
| 12.1.2.Instruments |
| 12.2. Technology Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.PCR |
| 12.2.2.ELISA |
| 12.2.3.Direct Assay |
| 12.2.4.Indirect Assay |
| 12.2.5.Enzymatic Methods |
| 12.2.6.DNA Staining |
| 12.2.7.Others |
| 12.3. Application Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.Cell Line Testing |
| 12.3.2.Virus Testing |
| 12.3.3.Others |
| 12.4. End User Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.4.1.Academic Research Institutes |
| 12.4.2.Cell Banks |
| 12.4.3.Pharmaceutical & Biotechnology Companies |
| 12.4.4.Others |
| 12.5. Country Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.5.1.China |
| 12.5.2.India |
| 12.5.3.Australia and New Zealand (ANZ) |
| 12.5.4.Japan |
| 12.5.5.Rest of APAC |
| 13.Middle East and Africa (MEA) Mycoplasma Testing Market ,2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
| 13.1. Product Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.1.1.Kits & Reagents |
| 13.1.2.Instruments |
| 13.2. Technology Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.2.1.PCR |
| 13.2.2.ELISA |
| 13.2.3.Direct Assay |
| 13.2.4.Indirect Assay |
| 13.2.5.Enzymatic Methods |
| 13.2.6.DNA Staining |
| 13.2.7.Others |
| 13.3. Application Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.3.1.Cell Line Testing |
| 13.3.2.Virus Testing |
| 13.3.3.Others |
| 13.4. End User Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.4.1.Academic Research Institutes |
| 13.4.2.Cell Banks |
| 13.4.3.Pharmaceutical & Biotechnology Companies |
| 13.4.4.Others |
| 13.5. Country Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.5.1.GCC Countries |
| 13.5.2.South Africa |
| 13.5.3.Rest of MEA |
| 14.Latin America Mycoplasma Testing Market ,2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
| 14.1. Product Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.1.1.Kits & Reagents |
| 14.1.2.Instruments |
| 14.2. Technology Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.2.1.PCR |
| 14.2.2.ELISA |
| 14.2.3.Direct Assay |
| 14.2.4.Indirect Assay |
| 14.2.5.Enzymatic Methods |
| 14.2.6.DNA Staining |
| 14.2.7.Others |
| 14.3. Application Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.3.1.Cell Line Testing |
| 14.3.2.Virus Testing |
| 14.3.3.Others |
| 14.4. End User Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.4.1.Academic Research Institutes |
| 14.4.2.Cell Banks |
| 14.4.3.Pharmaceutical & Biotechnology Companies |
| 14.4.4.Others |
| 14.5. Country Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.5.1.Brazil |
| 14.5.2.Mexico |
| 14.5.3.Rest of LA |
| 15. Competition Landscape |
| 15.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 15.2.1.Thermo Fisher Scientific, Inc. (US) |
| 15.2.2.Charles River Laboratories International, Inc. (US) |
| 15.2.3.Lonza Group Ltd. (Switzerland), |
| 15.2.4.Merck KGaA (Germany), |
| 15.2.5.Roche Diagnostics (Switzerland) |
| 15.2.6.American Type Culture Collection (US) |
| 15.2.7.Bionique Testing Laboratories, Inc. (US) |
| 15.2.8.InvivoGen (US) |
| 15.2.9.PromoCell GmbH (Germany) |
| 15.2.10.Biological Industries Israel Beit Haemek Ltd. (Israel) |
| 16. Research Methodology |
| 17. Appendix and Abbreviations |
- Thermo Fisher Scientific, Inc. (US)
- Charles River Laboratories International, Inc. (US)
- Lonza Group Ltd. (Switzerland),
- Merck KGaA (Germany),
- Roche Diagnostics (Switzerland)
- American Type Culture Collection (US)
- Bionique Testing Laboratories, Inc. (US)
- InvivoGen (US)
- PromoCell GmbH (Germany)
- Biological Industries Israel Beit Haemek Ltd. (Israel)